Nardella, Caterina
 Distribuzione geografica
Continente #
NA - Nord America 2.396
AS - Asia 864
EU - Europa 517
SA - Sud America 119
Continente sconosciuto - Info sul continente non disponibili 54
AF - Africa 15
OC - Oceania 3
Totale 3.968
Nazione #
US - Stati Uniti d'America 2.354
SG - Singapore 356
CN - Cina 208
RU - Federazione Russa 112
BR - Brasile 99
VN - Vietnam 98
IT - Italia 90
GB - Regno Unito 49
FR - Francia 45
KR - Corea 35
FI - Finlandia 34
SE - Svezia 33
HK - Hong Kong 32
IN - India 30
LV - Lettonia 28
DE - Germania 23
CA - Canada 22
TR - Turchia 22
BE - Belgio 18
BD - Bangladesh 16
IQ - Iraq 16
JP - Giappone 14
PL - Polonia 12
BG - Bulgaria 11
NL - Olanda 10
MX - Messico 9
ID - Indonesia 8
ZA - Sudafrica 8
AT - Austria 7
ES - Italia 7
CH - Svizzera 6
PK - Pakistan 6
UA - Ucraina 6
LT - Lituania 5
VE - Venezuela 5
AR - Argentina 4
CZ - Repubblica Ceca 4
SK - Slovacchia (Repubblica Slovacca) 4
HR - Croazia 3
IE - Irlanda 3
JM - Giamaica 3
PE - Perù 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
CL - Cile 2
CO - Colombia 2
EC - Ecuador 2
EG - Egitto 2
HU - Ungheria 2
JO - Giordania 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PR - Porto Rico 2
RO - Romania 2
TH - Thailandia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MA - Marocco 1
MK - Macedonia 1
MT - Malta 1
MV - Maldive 1
NO - Norvegia 1
PS - Palestinian Territory 1
PY - Paraguay 1
SA - Arabia Saudita 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.917
Città #
Chandler 289
Ashburn 260
Fairfield 250
Singapore 220
Woodbridge 114
Wilmington 102
Houston 99
Seattle 97
San Jose 86
Cambridge 76
Santa Clara 68
Dallas 61
Beijing 60
Columbus 52
Moscow 50
Princeton 50
San Mateo 43
The Dalles 41
Los Angeles 37
Seoul 35
Ann Arbor 34
Council Bluffs 34
Ho Chi Minh City 34
Hong Kong 28
Riga 28
Lauterbourg 26
Helsinki 22
Hanoi 21
Jacksonville 20
Trento 18
Brussels 17
São Paulo 17
Izmir 16
New York 16
San Diego 16
Orem 15
Chicago 13
London 13
Tokyo 13
Denver 12
Warsaw 11
Chennai 10
Hefei 10
Milan 10
Sofia 10
Toronto 10
Redondo Beach 9
Buffalo 8
Johannesburg 8
Kensington 8
Phoenix 8
Salt Lake City 8
Dearborn 7
Baghdad 6
Boston 6
Jakarta 6
Munich 6
Stockholm 6
Zurich 6
Atlanta 5
Da Nang 5
Falkenstein 5
Frankfurt am Main 5
Montreal 5
Paris 5
St Louis 5
Vienna 5
Amsterdam 4
Ankara 4
Elk Grove Village 4
Mexico City 4
Mumbai 4
Nanjing 4
Rio de Janeiro 4
Zhengzhou 4
Belo Horizonte 3
Biên Hòa 3
Boardman 3
Bratislava 3
Brooklyn 3
Caracas 3
Dublin 3
Edinburgh 3
Guangzhou 3
Lancaster 3
Lappeenranta 3
Miami 3
Milwaukee 3
Mosul 3
New Delhi 3
Ninh Bình 3
Norwalk 3
Ottawa 3
Pittsburgh 3
Poplar 3
Reston 3
San Francisco 3
Washington 3
Zagreb 3
Amman 2
Totale 2.802
Nome #
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer 188
Of model pets and cancer models: an introduction to mouse models of cancer 172
Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events 165
Editorial: Precision medicine in oncology 163
Differential requirement of mTOR in postmitotic tissues and tumorigenesis 159
MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells 157
Faithfull modeling of PTEN loss driven diseases in the mouse 157
Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesis 151
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis 151
Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer 147
Subtle variations in Pten dose determine cancer susceptibility 145
ETS rearrangements and prostate cancer initiation 143
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate 140
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation 137
Integrating extracellular vesicle and circulating cell-free DNA analysis on a single plasma aliquot improves the detection of HER2 positivity in breast cancer patients 137
Circulating RNAs in prostate cancer patients 134
Mechanism of Activation of Human Heparanase Investigated by Protein Engineering 133
Pro-senescence therapy for cancer treatment 130
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer 129
Radiolabeled heparan sulfate immobilized on microplate as substrate for the detection of heparanase activity 127
Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence 126
Characterization of the hepatitis C virus NS2/3 processing reaction by using a purified precursor protein 126
Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion 124
The APL paradigm and the "co-clinical trial" project 119
Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition 117
Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis 113
International Society for Extracellular Vesicles Workshop. QuantitatEVs: multiscale analyses, from bulk to single extracellular vesicle 101
Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence 89
MYC-driven gliosis impairs neuron-glia communication in amyotrophic lateral sclerosis 88
Totale 3.968
Categoria #
all - tutte 19.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.020


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022215 0 6 0 18 6 12 4 63 18 42 10 36
2022/2023537 38 65 2 79 55 91 0 63 89 6 37 12
2023/2024137 16 22 6 6 11 21 13 2 4 8 6 22
2024/2025722 0 0 50 133 75 91 14 36 91 137 48 47
2025/20261.300 105 31 145 232 181 113 172 32 135 85 37 32
2026/202782 37 45 0 0 0 0 0 0 0 0 0 0
Totale 3.968